Questions and Answers from the F.I.X. Ketorolac Continuous Infusion Pregnancy and Newer NSAIDs Article Review: Medication Errors and Adverse Drug Events in Pediatric Inpatients
Restricted accessOtherFirst published online February, 2002
Questions and Answers from the F.I.X. Ketorolac Continuous Infusion Pregnancy and Newer NSAIDs Article Review: Medication Errors and Adverse Drug Events in Pediatric Inpatients
The Formulary Information Exchange (The F.I.X.) is an online drug information service available to subscribers to The Formulary Monograph Service at http://theformu-lary.com, or you may log on through drugfacts.com. In this column, we present samples of recent dialog on The F.I.X. If you would like more information on The Formulary Monograph Service or The F.I.X., please call 800-322-4349. If you would like to comment on any of the following questions or answers
Get full access to this article
View all access options for this article.
References
1.
Letter from Pharmacia: Use of Celebrex (celecoxib) during pregnancy and lactation.Skokie, IL: Pharmacia Healthcare Information Services; November 5, 2001.
2.
Letter from Merck: Use of Vioxx (rofecoxib) during pregnancy and lactation.West Point, PA: Medical Services, Merck Human Health Division; November 6, 2001.
3.
RathmellJ.Management of nonobstetric pain during pregnancy and lactation. Anesth Analg.1997; 85: 1074–87.
EvertsB., WahrborgP., HednerT.COX-2 specific inhibitors: The emergence of a new class of analgesic and antiinflammatory drugs. Clin Rheumatol.2000; 19(5): 331–43.
6.
AubeM.Migraine in pregnancy. Neurology.1999; 52(S1): S26–28.
7.
OstensenM., OstensenH.Safety of nonsteroidal antiinflammatory drugs in pregnant patients with rheumatic disease. J Rheumatol.1996; 23(6): 1045–9.
8.
OstensenM., Ramsey-GoldmanR.Treatment of inflammatory rheumatic disorders in pregnancy. Drug Saf.1998; 19(5): 389–410.
9.
BriggsG.G., FreemanR.K., YaffeS.J.Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk.5th ed.Baltimore: Williams & Wilkins;1998.
